1
-
5
of
5
results (0.39 seconds)
Sort By:
-
Biosimilars, Part 4: The Financial Impact
Part 4: The Financial Impact Savings from biosimilars have accelerated significantly in the past few ... number of relatively recent biosimilar launches that can help to shape our expectations of the financial ...- Authors: Greg Warren, Tony Pistilli
- Date: Nov 2023
- Competency: External Forces & Industry Knowledge; Strategic Insight and Integration
- Publication Name: Health Watch
- Topics: Health & Disability; Health & Disability>Health care; Health & Disability>Health insurance; Public Policy; Public Policy; Public Policy
-
Biosimilars, Part 1: A Brief Introduction
drugs? Are they the same as generic drugs? What potential impact might Biosimilars have in the United States ... original publication on the Axene Health Partners website. The coming market introduction of several significant ...- Authors: Gregory Warren, Tony Pistilli
- Date: Sep 2023
- Competency: External Forces & Industry Knowledge
- Publication Name: Health Watch
- Topics: Health & Disability
-
Biosimilars, Part 3: Humira Biosimilar Launches
3: Humira Biosimilar Launches The big event of 2023 is the launch of multiple Humira biosimilars, which ... with the arrival of Amgen’s Amjevita on the market. The launch of Amjevita kicks off the process of changing ...- Authors: Tony Pistilli, Greg Warren
- Date: Nov 2023
- Competency: External Forces & Industry Knowledge; Strategic Insight and Integration
- Publication Name: Health Watch
- Topics: Health & Disability; Health & Disability>Health care; Health & Disability>Health insurance; Public Policy; Public Policy; Public Policy
-
healthcare-sharing-ministries
coverage. Further exploring HCSMs, some of the offered arrangements of this plan operate differently and with ... has grown 1000% since solidification as a law in the ACA. By signing up for this webcast, you can discover ...- Authors: Tony Pistilli, Rob Nordstrom, Scott Reddig, Joshua Axene
- Date: Feb 2023
- Competency: External Forces & Industry Knowledge; Strategic Insight and Integration
- Topics: Health & Disability; Public Policy
-
2022-biologic-drugs
understanding of specialty drug trends and their increasing healthcare costs for more than the past decade ... this webcast. With the introduction of price competition, you will see changes in the market for biosimilar ...- Authors: Tony Pistilli, Greg Warren
- Date: Jul 2023
- Competency: External Forces & Industry Knowledge; Results-Oriented Solutions; Strategic Insight and Integration
- Topics: Health & Disability; Public Policy